Anyway, it remains controversial the prognostic role of FAK in breast cancer considering that diverse studies, including multivariate analysis of breast cancer subtypes, failed to assess correlations between FAK expression and clinical outcomes like the OS or the DFS [209,210]. The gene discussed is PTK2; the disease is breast cancer.